The global magnetic beads market reached USD 2.8 billion in 2025 and is projected to reach USD 6.8 billion by 2034. ResearchAndMarkets.com added a 145-page report covering the market's outlook from 2025 to 2034; its narrative forecasts a 9.88% compound annual growth rate from 2026 to 2034, while the report attributes table lists 9.8%. Demand is being supported by molecular diagnostics, next-generation sequencing, biomolecule separation and purification, genetic research, nanotechnology-based analytical methods and in-vitro diagnostics. Magnetic beads are used to isolate and purify DNA, RNA, proteins, plasmids and other biomolecules across research and clinical workflows. The report covers cells, pathogenic microorganisms, nucleic acids, peptides, proteins and other product types; superparamagnetic and ferrimagnetic cores; four size categories; and applications including sequencing, biomolecule separation and purification, and molecular and immunodiagnostics. North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa are covered, alongside country-level markets. COVID-19 increased the importance of rapid and accurate screening and supported demand for sample preparation and purification products. Longer life expectancy, chronic disease research, biotechnology investment and emerging wastewater-treatment and agricultural uses are also identified as market-supporting factors. The competitive landscape includes Bangs Laboratories, Bio-Rad Laboratories, GenScript, Merck KGaA, Miltenyi Biotec, New England Biolabs, Promega, Qiagen, Rockland Immunochemicals, Takara Bio, Thermo Fisher Scientific and Vazyme International.